Molecular Formula | C20H21N7O3 |
Molar Mass | 407.43 |
Density | 1.55±0.1 g/cm3(Predicted) |
Melting Point | 169-171°C |
Boling Point | 676.9±65.0 °C(Predicted) |
Solubility | DMSO:≥ 125 mg/mL |
Appearance | solid |
Color | Beige |
pKa | 4.05±0.30(Predicted) |
Storage Condition | -20°C |
Stability | Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 3 months. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.454 ml | 12.272 ml | 24.544 ml |
5 mM | 0.491 ml | 2.454 ml | 4.909 ml |
10 mM | 0.245 ml | 1.227 ml | 2.454 ml |
5 mM | 0.049 ml | 0.245 ml | 0.491 ml |
application | CPI-444 is an effective selective A2A receptor (A2AR) inhibitor to induce anti-tumor response. |
use | CPI-444 is an oral antagonist of A2A receptor, which binds to adenosine receptor on the surface of immune cells. |
biological activity | Ciforadenant(CPI-444, V81444) is an effective selective Adenosine A2A receptor antagonist, which binds to A2AR with a Ki value of 3.54 nM, and its selectivity to A2AR is more than 50 times higher than that of other adenosine receptor subtypes. |
target | TargetValue A2AR () 3.54 nM(Ki) |
Target | Value |
A2AR () | 3.54 nM(Ki) |